InvestorsHub Logo
Followers 138
Posts 23699
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Saturday, 01/28/2017 11:14:45 AM

Saturday, January 28, 2017 11:14:45 AM

Post# of 807
CTL019 therapy for multiple myeloma from Oxford BioMedica and Novartis

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646711/

We report a sustained complete response to an infusion of CTL019 cells in conjunction with autologous transplantation in a patient with advanced multiple myeloma.



The patient described here benefited from CTL019 without the development of the cytokine release syndrome.



Good luck and GOD bless,

George